Prospective study comparing hyoscyamine, doxazosin, and combination therapy for the treatment of urgency and frequency in women

Neurourology and Urodynamics

Volumn 17, Issue 1, 1998, Pages 31-36

  Serels, Scott ^a,b   Stein, Mark ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

AUA symptom score; Drug therapy; Frequency; Urgency; Urodynamics

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; HYOSCYAMINE;

ADULT; AGED; ARTICLE; BLADDER DISTENSION; BLADDER PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; HEADACHE; HUMAN; LEG EDEMA; MICTURITION; URGE INCONTINENCE; URINE INCONTINENCE; URODYNAMICS; VERTIGO; XEROSTOMIA;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ATROPINE; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DOXAZOSIN; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MIDDLE AGED; MUSCARINIC ANTAGONISTS; PROSPECTIVE STUDIES; SAFETY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; URINARY BLADDER; URINARY INCONTINENCE; URODYNAMICS;

EID: 0031984164     PISSN: 07332467     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6777(1998)17:1<31::AID-NAU6>3.0.CO;2-E     Document Type: Article

References (15)

1. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrene HL, Mebust WK, Cockett AT (1992): The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 148:1549-1557.
2. Burgio KL, Matthews KA, Engel BT (1991): Prevalence, incidence and correlates of urinary incontinence in healthy, middle-aged women. J Urol 146:1255-1259.
3. Di Silverio F (1992): Use of terazosin in the medical treatment of benign prostatic hyperplasia: Expression in Italy. Br J Urol [Suppl] 70:22-26.
4. Jolleys JV (1990): The reported prevalence of urinary symptoms in women in one rural general practice. Br J Gen Pract 40:335-337.
5. Lepor H, Machi G (1993): Comparison of AUA symptom index in unselected males between fifty-five and seventy-nine years of age. Urology 42:36-40.
6. Lepor H, Theune C (1995): Randomized double-blind study comparing the efficacy of terazosin versus placebo in women with prostatism-like symptoms. J Urol 154:116-118.
7. Lepor H, Auerbach S, Puras-Baez A, Narayan P, Soloway M, Lowe F, Moon T, Leifer G, Madsen P (1992): A randomized placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. J Urol 148:1467-1474.
8. Lloyd SN, Buckley JF, Chilton CP, Ibrahim I, Kaisary AV, Kirk D (1992): Terazosin in the treatment of benign prostatic hyperplasia: A multicentre, placebo-controlled trial. Br J Urol [Suppl] 70:17-21.
9. Moisey CU, Stephenson TP, Brendler CB (1980): The urodynamic and subjective results of treatment of detrusor instability with oxybutynin chloride. J Urol 52:472-475.
10. Moore MH, Hay DM, Imrie AE, Watson A, Goldstein M (1990): Oxybutynin hydrochloride (3 mg) in the treatment of women with idiopathic detrusor instability. Br J Urol 66:479-485.
11. Stanton SL, Ozsoy C, Hilton P (1983): Voiding difficulties in the female: Prevalence, clinical and urodynamic review. Obstet Gynecol 61:144-147.
12. Swierzewski SJ, Gormley EA, Belville WD, Sweetser PM, Wan J, McGuire EJ (1994): The effect of terazosin on bladder function in the spinal cord injured patient. J Urol 151:951-954.
13. Tapp A, Fall M, Norgaard J, Massey A, Choa R, Carr T, Korhonen M, Abrams P (1989): Terodiline: A dose titrated, multicenter study of the treatment of idiopathic detrusor instability in women. J Urol 142:1027-1031.
14. Wein AJ (1985): Pharmacologic treatment of lower urinary tract dysfunction in the female patient. Urol Clin North AM 12:259-269.
15. Wein AJ (1992): Neuromuscular dysfunction of the lower urinary tract. In Walsh PC, Retik AB, Stamey TA, Vaughan ED (eds.) "Campbell's Urology," Vol 1, 6th ed. Philadelphia: W.B. Saunders Co., pp 499-521.